SCLN 8.68 Sciclone Pharmaceuticals $SCLN Hit a 52 week high of 8.74 Closing the day 09:44 at 8.68 +0.01 +0.12% With a day low of 8.42 and a total volume of 79,364.
SCLN Recent Posts: http://investorshangout.com/Sciclone-Pharmace...CLN-55380/
SCLN Sciclone Pharmaceuticals Recent Headline News
SciClone reports lower Q3 2014 GAAP net income of USD7.9m
M2 - Wed Nov 12, 7:18AM CST
Pharmaceutical company SciClone Pharmaceuticals (NasdaqGS:SCLN) disclosed on Tuesday its GAAP net income of USD7.9m (USD0.16 & USD0.15 per share, basic and diluted, respectively) for the Q3 2014.
SCLN: 8.63 (-0.04)
SciClone Pharma ups earnings guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:47AM CST
SCLN: 8.63 (-0.04)
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 8:47PM CST
SCLN: 8.63 (-0.04)
SciClone Pharmaceuticals (SCLN) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST
SCLN: 8.63 (-0.04)
SciClone Pharmaceuticals beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:16PM CST
SCLN: 8.63 (-0.04)
SciClone Reports Financial Results for the Third Quarter 2014
Marketwired - Mon Nov 10, 3:06PM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the third quarter 2014.
SCLN: 8.63 (-0.04)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST
HK: 3.06 (+0.01), WWD: 50.49 (-0.74), LLNW: 2.69 (unch), FXEN: 2.63 (-0.06), RMTI: 11.13 (-0.11), CZR: 15.54 (+1.87), EGY: 7.12 (+0.09), ICUI: 83.74 (-0.99), ICEL: 7.54 (-0.13), SAAS: 8.74 (-0.06), DMD: 5.42 (-0.28), NPSP: 29.36 (+0.19), SCLN: 8.63 (-0.04), ATHX: 1.40 (-0.03), CMLS: 3.28 (-0.07), TC: 1.99 (-0.06), ATW: 34.70 (-0.82), CLUB: 5.88 (-0.09), RAX: 43.66 (+1.06), PTLA: 26.46 (-1.28), IPAR: 28.41 (-0.44), ATLS: 36.53 (-0.24), AMBC: 26.15 (-0.34), CUI: 7.15 (-0.62), PDLI: 7.89 (-0.13), OMER: 19.36 (-0.35), PRAA: 62.14 (-0.19), CARA: 8.09 (+0.01), HALO: 8.80 (-0.18), MODN: 10.48 (-0.02), CALL: 8.38 (-0.30), ASEI: 44.01 (-0.76), HGR: 21.04 (+0.33), ERII: 4.86 (+0.03)
Sciclone Pharmaceuticals Has Returned 41.6% Since SmarTrend Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Nov 07, 10:59AM CST
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 3 months, Sciclone Pharmaceuticals has returned 41.62% as of today's recent price of $7.69.
SCLN: 8.63 (-0.04)
SciClone to Present at Jefferies Global Healthcare Conference on November 19th
Marketwired - Thu Nov 06, 5:00AM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview and business update at the Jefferies Global Healthcare Conference on November 19, 2014, at 4:20 pm GMT, taking place at the Waldorf Hilton Hotel in London, England.
SCLN: 8.63 (-0.04)
SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10th
Marketwired - Thu Oct 30, 5:01AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the third quarter 2014 on Monday, November 10, 2014. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that day. The call will be hosted by Friedhelm Blobel, Ph.D., President and CEO, and Wilson W. Cheung, Senior Vice President and CFO.
SCLN: 8.63 (-0.04)
Sciclone Pharmaceuticals Shares Up 44.4% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Oct 24, 9:09AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 44.38% as of today's recent price of $7.84.
SCLN: 8.63 (-0.04)
3 Biotech Stocks Near 52-Week Highs Worth Selling
Motley Fool Staff - Motley Fool - Wed Oct 22, 12:01PM CDT
With markets dropping-and-popping this month investors are right to wonder whether rising volatility means that it's a good time to be moving out of high flying stocks. But just because a stock is hitting new highs doesn't mean that it isn't a great...
MACK: 8.33 (-0.22), BCRX: 10.53 (-0.25), BAX: 72.05 (+0.72), SCLN: 8.63 (-0.04), GSK: 45.64 (+0.02), CELG: 106.71 (-1.54)
Sciclone Pharmaceuticals Shares Up 26.7% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Thu Oct 09, 11:01AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 26.70% as of today's recent price of $6.88.
SCLN: 8.63 (-0.04)
Uptrend Call Working As Sciclone Pharmaceuticals Stock Rises 27.3% (SCLN)
Comtex SmarTrend(R) - Thu Oct 02, 9:42AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 27.26% as of today's recent price of $6.91.
SCLN: 8.63 (-0.04)
SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014
Marketwire - Wed Sep 17, 5:00AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at the 2014 BioCentury NewsMakers in the Biotech Industry conference at 11:30 am ET on Friday, September 26, 2014, at the Millennium Broadway Hotel & Conference Center in New York City.
SCLN: 8.63 (-0.04)
30.2% Return Seen to Date on SmarTrend Sciclone Pharmaceuticals Call (SCLN)
Comtex SmarTrend(R) - Wed Sep 10, 11:02AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 4 weeks, Sciclone Pharmaceuticals has returned 30.20% as of today's recent price of $7.07.
SCLN: 8.63 (-0.04)
SCLN Recent Posts: http://investorshangout.com/Sciclone-Pharmace...CLN-55380/
SCLN Sciclone Pharmaceuticals Recent Headline News
SciClone reports lower Q3 2014 GAAP net income of USD7.9m
M2 - Wed Nov 12, 7:18AM CST
Pharmaceutical company SciClone Pharmaceuticals (NasdaqGS:SCLN) disclosed on Tuesday its GAAP net income of USD7.9m (USD0.16 & USD0.15 per share, basic and diluted, respectively) for the Q3 2014.
SCLN: 8.63 (-0.04)
SciClone Pharma ups earnings guidance after Q3 results
Seeking Alpha - at Seeking Alpha - Tue Nov 11, 10:47AM CST
SCLN: 8.63 (-0.04)
SciClone Pharmaceuticals' (SCLN) CEO Friedhelm Blobel on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Nov 10, 8:47PM CST
SCLN: 8.63 (-0.04)
SciClone Pharmaceuticals (SCLN) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Nov 10, 3:25PM CST
SCLN: 8.63 (-0.04)
SciClone Pharmaceuticals beats by $0.05, misses on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 3:16PM CST
SCLN: 8.63 (-0.04)
SciClone Reports Financial Results for the Third Quarter 2014
Marketwired - Mon Nov 10, 3:06PM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the third quarter 2014.
SCLN: 8.63 (-0.04)
Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Nov 09, 4:35PM CST
HK: 3.06 (+0.01), WWD: 50.49 (-0.74), LLNW: 2.69 (unch), FXEN: 2.63 (-0.06), RMTI: 11.13 (-0.11), CZR: 15.54 (+1.87), EGY: 7.12 (+0.09), ICUI: 83.74 (-0.99), ICEL: 7.54 (-0.13), SAAS: 8.74 (-0.06), DMD: 5.42 (-0.28), NPSP: 29.36 (+0.19), SCLN: 8.63 (-0.04), ATHX: 1.40 (-0.03), CMLS: 3.28 (-0.07), TC: 1.99 (-0.06), ATW: 34.70 (-0.82), CLUB: 5.88 (-0.09), RAX: 43.66 (+1.06), PTLA: 26.46 (-1.28), IPAR: 28.41 (-0.44), ATLS: 36.53 (-0.24), AMBC: 26.15 (-0.34), CUI: 7.15 (-0.62), PDLI: 7.89 (-0.13), OMER: 19.36 (-0.35), PRAA: 62.14 (-0.19), CARA: 8.09 (+0.01), HALO: 8.80 (-0.18), MODN: 10.48 (-0.02), CALL: 8.38 (-0.30), ASEI: 44.01 (-0.76), HGR: 21.04 (+0.33), ERII: 4.86 (+0.03)
Sciclone Pharmaceuticals Has Returned 41.6% Since SmarTrend Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Nov 07, 10:59AM CST
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 3 months, Sciclone Pharmaceuticals has returned 41.62% as of today's recent price of $7.69.
SCLN: 8.63 (-0.04)
SciClone to Present at Jefferies Global Healthcare Conference on November 19th
Marketwired - Thu Nov 06, 5:00AM CST
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, Ph.D., Chief Executive Officer, will present a corporate overview and business update at the Jefferies Global Healthcare Conference on November 19, 2014, at 4:20 pm GMT, taking place at the Waldorf Hilton Hotel in London, England.
SCLN: 8.63 (-0.04)
SciClone Pharmaceuticals to Report Financial Results for the Third Quarter 2014 on November 10th
Marketwired - Thu Oct 30, 5:01AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that it plans to report financial results for the third quarter 2014 on Monday, November 10, 2014. SciClone will host a conference call and webcast to provide a business and product update at 4:30 pm ET (1:30 pm PT) that day. The call will be hosted by Friedhelm Blobel, Ph.D., President and CEO, and Wilson W. Cheung, Senior Vice President and CFO.
SCLN: 8.63 (-0.04)
Sciclone Pharmaceuticals Shares Up 44.4% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Fri Oct 24, 9:09AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 44.38% as of today's recent price of $7.84.
SCLN: 8.63 (-0.04)
3 Biotech Stocks Near 52-Week Highs Worth Selling
Motley Fool Staff - Motley Fool - Wed Oct 22, 12:01PM CDT
With markets dropping-and-popping this month investors are right to wonder whether rising volatility means that it's a good time to be moving out of high flying stocks. But just because a stock is hitting new highs doesn't mean that it isn't a great...
MACK: 8.33 (-0.22), BCRX: 10.53 (-0.25), BAX: 72.05 (+0.72), SCLN: 8.63 (-0.04), GSK: 45.64 (+0.02), CELG: 106.71 (-1.54)
Sciclone Pharmaceuticals Shares Up 26.7% Since SmarTrend's Buy Recommendation (SCLN)
Comtex SmarTrend(R) - Thu Oct 09, 11:01AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 26.70% as of today's recent price of $6.88.
SCLN: 8.63 (-0.04)
Uptrend Call Working As Sciclone Pharmaceuticals Stock Rises 27.3% (SCLN)
Comtex SmarTrend(R) - Thu Oct 02, 9:42AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 2 months, Sciclone Pharmaceuticals has returned 27.26% as of today's recent price of $6.91.
SCLN: 8.63 (-0.04)
SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014
Marketwire - Wed Sep 17, 5:00AM CDT
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that Friedhelm Blobel, PhD, Chief Executive Officer, will present a corporate overview and business update at the 2014 BioCentury NewsMakers in the Biotech Industry conference at 11:30 am ET on Friday, September 26, 2014, at the Millennium Broadway Hotel & Conference Center in New York City.
SCLN: 8.63 (-0.04)
30.2% Return Seen to Date on SmarTrend Sciclone Pharmaceuticals Call (SCLN)
Comtex SmarTrend(R) - Wed Sep 10, 11:02AM CDT
SmarTrend identified an Uptrend for Sciclone Pharmaceuticals (NASDAQ:SCLN) on August 12th, 2014 at $5.43. In approximately 4 weeks, Sciclone Pharmaceuticals has returned 30.20% as of today's recent price of $7.07.
SCLN: 8.63 (-0.04)
